Key Points Dividend growth has been robust, stretching back decades. Cash generation is trending higher this year, improving dividend safety. The stock is not cheap, but a durable business like this deserves to trade at a high valuation. 10 stocks we like better than Waste Management › Investors looking for dividend income do not have to choose between income and business quality. Waste Management (NYSE: WM), the largest North American provider of waste collection, recycling, and landfill service ...

Enterprise Products Partners L.P. (NYSE:EPD) is included among the 11 Best Affordable Dividend Stocks to Buy Now. Enterprise Products Partners’ (EPD) Dividend Track Record Makes it a Strong Affordable Dividend Stock Choice Enterprise Products Partners L.P. (NYSE:EPD) is one of the largest midstream oil and gas operators in North America. The critical connection between upstream production and downstream refining and chemical processing is provided by the midstream portion of the energy industry. It just ...

Group 1 - The Southern Company (NYSE:SO) is recognized as one of the Best Dividend Stocks and is included in the Dividend Champions List [1][2] - The company operates electric and gas utilities, as well as providing fiber-optic and wireless communication services, serving over 9 million customers in the Southeast [2] - Southern Company has a significant presence in nuclear energy, managing eight reactors across three facilities, including the recently launched Vogtle Units 3 and 4, marking the first new commercial reactors in the US in about thirty years [3] Group 2 - Utility stocks, including Southern Company, are generally viewed as stable investments due to consistent energy demand and regulatory frameworks that stabilize prices and support infrastructure investment [4] - Southern Company has a strong track record with 24 consecutive years of dividend increases and has paid dividends without interruption for 78 years, with a current quarterly dividend of $0.74 per share and a dividend yield of 3.15% as of October 2 [4]

Core Viewpoint - Amgen's stock presents an attractive long-term investment opportunity despite recent share price declines and upcoming patent cliffs [1][2]. Group 1: Promising Drug Developments - Amgen is developing MariTide, a weight management drug that has shown a mean weight loss of up to 20% over 52 weeks, with a favorable monthly dosing schedule [4][5]. - The anti-obesity market is rapidly growing, and MariTide could generate sales of up to $3.7 billion by 2030, helping Amgen offset losses from patent expirations [6]. - Amgen has a robust pipeline with several ongoing programs, including bemarituzumab, which has shown promising results in a phase 3 study for metastatic gastric cancer [7][8]. Group 2: Recent Product Launches - Amgen's recent product approvals, such as Imdelltra for lung cancer, Tezspire for asthma, and Uplizna for rare diseases, are expected to contribute to top-line growth [9][10]. Group 3: Financial Strength and Dividends - Amgen has a strong dividend track record, having increased its dividend by 201.3% over the past decade, with a current yield of 3.5% [11][12]. - The company's cash payout ratio of 46.5% provides room for further dividend increases, making it an attractive option for investors seeking income [12][13]. Group 4: Valuation - Amgen's shares are considered reasonably valued, with a forward price-to-earnings ratio of 12.6, lower than the healthcare industry average of 16.4 [14][15]. - The market may be pricing in upcoming patent losses, but long-term investors could benefit from potential revenue and earnings growth as new products are launched [15].

Altria Group, Inc. (NYSE:MO) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500. Why Dividend Investors Keep an Eye on Altria Group’s (MO) Payouts Altria Group, Inc. (NYSE:MO) is an American company and one of the world’s leading producers and marketers of tobacco products, including cigarettes, as well as medical products designed to treat conditions related to tobacco use. The iconic company, best known for its Marlboro cigarettes, has long been a popular choice for dividend ...

Healthpeak Properties, Inc. (NYSE:DOC) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500. Dividend Dependability: How Healthpeak Properties (DOC) Supports Long-Term Income Strategies Healthpeak Properties, Inc. (NYSE:DOC) is heavily exposed to healthcare real estate, with a focus on outpatient medical centers, senior living, and life science labs. Its portfolio includes more than 278 properties across 32 states, with a strong leasing occupancy rate of 94%. It depends on triple ...

Roughly half of all U.S. stocks pay dividends, making it a huge investable universe, with this one ETF letting you buy the best of the best.The U.S. market is huge, with a combined market cap of around $63 trillion. There are all sorts of different ways you can slice and dice the U.S. stock market, with the top ETFs offering plenty of variety. But if you are a dividend lover, you are only interested in about half of the total universe, which cuts your investable universe down to "just" $30 trillion or so.If ...

Schwab US Dividend Equity ETF TodaySCHDSchwab US Dividend Equity ETF$27.10 -0.11 (-0.40%) 52-Week Range$23.87▼$29.72Dividend Yield3.80%Assets Under Management$71.29 billionAdd to WatchlistFinancial markets are all about rotation. Not all assets move together, and money constantly shifts based on where investors see the best balance of risk and reward. With the Federal Reserve cutting rates in September 2025, many expect high-yielding assets to gain traction in the coming months. One of the most popular des ...

Group 1 - Lockheed Martin Corporation (LMT) is recognized as one of the 10 Best Recession Proof Dividend Stocks to Buy, highlighting its resilience in economic downturns [1] - The company operates primarily in the defense and aerospace sectors, with significant contracts from the federal government, including projects like the F-35 combat aircraft and missile defense systems [2][3] - Lockheed Martin benefits from a strong backlog of contracts due to its established reputation and partnerships with the US government, ensuring revenue visibility for the future [3] Group 2 - Despite fluctuations in defense spending, Lockheed Martin maintains steady profits through a diverse portfolio and a solid baseline of funding, making it largely independent of broader economic cycles [4] - The company has a strong dividend history, having increased its payouts for 22 consecutive years, with a current quarterly dividend of $3.30 per share and a dividend yield of 2.71% as of September 26 [4]

Group 1 - The article emphasizes the advantages of investing in dividend exchange-traded funds (ETFs) over individual dividend stocks, highlighting the benefits of regular payouts and diversification [1] - The Schwab U.S. Dividend Equity ETF (SCHD) is identified as a top choice for income investors in 2025, particularly due to its strong performance and low expense ratio [2][4] - The SCHD ETF tracks the Dow Jones U.S. Dividend 100 Index, focusing on stocks with a history of consistent dividend payouts and superior fundamentals [3] Group 2 - The SCHD ETF has a low expense ratio of 0.06%, translating to $6 in annual fees per $10,000 invested, and manages total net assets of $71 billion [4] - The top holdings of the SCHD ETF include companies from dividend-friendly sectors such as healthcare, energy, consumer cyclical, and industrial [5] - The SCHD ETF offers one of the highest dividend yields compared to other funds in its class, making it appealing for income-focused investors [7][9] Group 3 - While the SCHD ETF provides consistent payouts, the actual distribution amounts may vary due to different dividend schedules of the underlying companies [5] - The article notes a limited exposure to the technology sector within the SCHD ETF, which may be a concern for investors looking to capitalize on tech trends [10] - Investors are advised to consider adding a tech ETF or top-performing tech stocks to their portfolio for exposure to major trends like artificial intelligence, alongside the SCHD ETF [11]